Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576016 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 950
- Enrollment target
NCT01576016 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 950 participants.
The verdict
NCT01576016, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 950 participants
- Enrollment target
Study Summary
The MRI Study is a prospective, multi-center, clinical study designed to evaluate the safety and efficacy of the Accent MRI™ System in a patient population indicated for implant of a pacemaker within and outside of the MRI environment.
Interventions
- DEVICE Accent MRI system (lead safety)
- DEVICE Accent MRI system (with MRI scan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 2012-03-30 |
| Est. Completion | 2018-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576016
The ClinicalTrials.gov registry entry for NCT01576016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 950 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Accent MRI system (lead safety) is the first listed.
NCT01576016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576016 about?
NCT01576016 is a clinical study titled "Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead". The MRI Study is a prospective, multi-center, clinical study designed to evaluate the safety and efficacy of the Accent MRI™ System in a patient population indicated for implant of a pacemaker within and outside of the MRI environment.
What is the current status of trial NCT01576016?
This trial is currently completed. It is a NA study. The enrollment target is 950 participants. The study started on 2012-03-30. Estimated completion is 2018-02-02.
What interventions are being tested in trial NCT01576016?
The interventions under investigation include: Accent MRI system (lead safety) (DEVICE), Accent MRI system (with MRI scan) (DEVICE).
Who is sponsoring clinical trial NCT01576016?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.